explore -WSS

explore

author：focus 2025-09-30 20:18:24 - browse：32784

Wire medical stent -- coverage from STAT — Adobe

PHILADELPHIA — A new study, and the bold doctor who led it, could result in big questions about how researchers study medical devices and surgical treatments and, eventually, what procedures patients undergo.

It starts with coronary angioplasty, one of the most common procedures in medicine, performed hundreds of thousands of times a year in the U.S. alone. A balloon catheter is snaked up into a clogged artery in the heart and expanded to open the blood vessel. It leaves behind a metal scaffold, called a stent, that is used to prop the artery open.

In people who have just had a heart attack, this can be lifesaving. But frequently angioplasty is used mainly to relieve chest pain, or angina. And though this use dates back decades, angioplasty and stents have never passed the basic test any new pill for relieving symptoms has to clear: outperforming a placebo in a clinical trial where patients were blinded, meaning they don’t know whether they got the treatment or not.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Liquid biopsy for lung cancer is launched by Delfi

WSS

Do digital therapeutics have a future in medicine?

New Ultima Genomics DNA sequencer can read genome for $100

Analysis of telehealth claims data suggest service duplication

Vertex non

SAMSHA loosens regulations on methadone treatment centers

Analysis of telehealth claims data suggest service duplication

hotspot

explore

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

A virus, fished out of a lake, may have saved a man’s life

Walensky prepares to leave CDC — and Congress — behind

What to expect at HLTH 2023, the health care industry conference

Duchenne breakthrough therapy leaves behind pioneering families

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Heart attack and stroke risk calculators need revising

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Psychedelics group wrestles with new pharma identity

Analysis of telehealth claims data suggest service duplication

hotspot

Woodcock on FDA’s accelerated approval and her next chapter

Commercial surrogacy can be ethical, despite pope’s claims

What to expect at HLTH 2023, the health care industry conference

A virus, fished out of a lake, may have saved a man’s life

Novo Nordisk to expand supply of Wegovy for U.S. patients

New Ultima Genomics DNA sequencer can read genome for $100

leisure time

focus

leisure time

explore